Analyst Ratings for Enfusion Inc (ENFN)
ENFN Rating Summary
ENFN Price Target Summary
- Highest: $11.00 (Morgan Stanley)
- Lowest: $8.00 (Goldman Sachs)
- Average: $9.64
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$9.64 (+2.4%)
* Over Last 12-Mos
Rating Score: 3.3 / 10
Percentile Rank: 30%
Avg. $ Target:
$9.64 (+2.4%)
* Over Last 12-Mos
Rating Score: 3.3 / 10
Percentile Rank: 30%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/28/2024 | Goldman Sachs | Gabriela Borges | Downgrade | Sell (Neutral) |
8.00 (9.00) |
9.45 (9.42) |
-0.32% | Details |
| 1/30/2024 | JPMorgan | Alexei Gogolev | Downgrade | Underweight (Neutral) |
9.00 (11.00) |
8.43 (9.42) |
11.74% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
